Jennison Associates LLC Integra Lifesciences Holdings Corp Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$33.4 - $45.2 $279,958 - $378,866	8,382 Added 4.85%	181,299 $6.43 Million
Q4 2023 Feb 01, 2024	SELL	$34.21 - $44.59 $493,102 - $642,720	-14,414 Reduced 7.69%	172,917 $7.53 Million
Q3 2023 Oct 31, 2023	SELL	$37.8 - $45.97 $6.79 Million - $8.25 Million	-179,513 Reduced 48.93%	187,331 $7.15 Million
Q2 2023 Aug 03, 2023	BUY	$37.95 - $58.98 $256,466 - $398,586	6,758 Added 1.88%	366,844 $15.1 Million
Q1 2023 Apr 26, 2023	BUY	$52.61 - $60.49 $40,562 - $46,637	771 Added 0.21%	360,086 $20.7 Million
Q4 2022 Feb 09, 2023	BUY	$42.17 - $58.6 $799,121 - $1.11 Million	18,950 Added 5.57%	359,315 $20.1 Million
Q3 2022 Nov 01, 2022	BUY	$42.28 - $57.17 $2.75 Million - $3.71 Million	64,963 Added 23.59%	340,365 $14.4 Million
Q2 2022 Aug 02, 2022	BUY	$53.86 - $66.52 $3.73 Million - $4.61 Million	69,315 Added 33.63%	275,402 $14.9 Million
Q1 2022 May 11, 2022	SELL	$62.86 - $69.24 $78,072 - $85,996	-1,242 Reduced 0.6%	206,087 $13.2 Million
Q4 2021 Feb 08, 2022	BUY	$62.47 - $73.25 $3.58 Million - $4.2 Million	57,364 Added 38.25%	207,329 $13.9 Million
Q3 2021 Nov 09, 2021	SELL	$64.97 - $76.19 $11.2 Million - $13.1 Million	-172,545 Reduced 53.5%	149,965 $10.3 Million
Q2 2021 Aug 12, 2021	SELL	$66.79 - $76.63 $4.63 Million - $5.31 Million	-69,293 Reduced 17.69%	322,510 $22 Million
Q1 2021 May 11, 2021	SELL	$62.63 - $71.15 $896,548 - $1.02 Million	-14,315 Reduced 3.52%	391,803 $27.1 Million
Q4 2020 Feb 05, 2021	BUY	$43.31 - $66.55 $2.09 Million - $3.22 Million	48,322 Added 13.51%	406,118 $26.4 Million
Q3 2020 Nov 04, 2020	SELL	$43.33 - $51.72 $5 Million - $5.96 Million	-115,307 Reduced 24.37%	357,796 $16.9 Million
Q2 2020 Aug 06, 2020	SELL	$41.42 - $55.57 $8.17 Million - $11 Million	-197,181 Reduced 29.42%	473,103 $22.2 Million
Q1 2020 May 06, 2020	SELL	$36.67 - $61.04 $4.41 Million - $7.35 Million	-120,394 Reduced 15.23%	670,284 $29.9 Million
Q4 2019 Feb 07, 2020	BUY	$55.73 - $62.49 $3.23 Million - $3.62 Million	57,994 Added 7.92%	790,678 $46.1 Million
Q3 2019 Nov 08, 2019	SELL	$53.29 - $64.59 $4.82 Million - $5.85 Million	-90,502 Reduced 10.99%	732,684 $44 Million
Q2 2019 Aug 06, 2019	BUY	$46.45 - $55.85 $1.47 Million - $1.76 Million	31,582 Added 3.99%	823,186 $0
Q1 2019 May 10, 2019	SELL	$42.97 - $57.33 $2.94 Million - $3.92 Million	-68,333 Reduced 7.95%	791,604 $44.1 Million
Q4 2018 Feb 06, 2019	SELL	$42.62 - $64.51 $6.46 Million - $9.77 Million	-151,518 Reduced 14.98%	859,937 $38.8 Million
Q3 2018 Nov 08, 2018	SELL	$57.63 - $65.87 $187,124 - $213,879	-3,247 Reduced 0.32%	1,011,455 $66.6 Million
Q2 2018 Aug 02, 2018	SELL	$54.05 - $67.23 $7.66 Million - $9.52 Million	-141,648 Reduced 12.25%	1,014,702 $65.4 Million
Q1 2018 Apr 20, 2018	BUY	$46.55 - $57.38 $6.52 Million - $8.04 Million	140,045 Added 13.78%	1,156,350 $64 Million
Q4 2017 Jan 25, 2018	SELL	$46.22 - $51.77 $850,309 - $952,412	-18,397 Reduced 1.78%	1,016,305 $48.6 Million
Q3 2017 Nov 03, 2017	BUY	$47.8 - $53.63 $49.5 Million - $55.5 Million	1,034,702	1,034,702 $52.2 Million

Others Institutions Holding IART

# of Institutions

242

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$257 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$177 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$120 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$96.5 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$90.8 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.91B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account